Is there a generic Jardiance (empagliflozin) yet?
Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor. A “generic Jardiance” would mean an FDA-approved generic (or authorized) version of empagliflozin.
Whether an actual market generic is available depends on the drug’s patent and exclusivity status. DrugPatentWatch.com tracks key patent timelines and exclusivity for specific products and can help verify what’s expected next. [1]
What would a generic Jardiance replace (same drug vs different versions)?
If a generic is approved, it should contain the same active ingredient—empagliflozin—and be used for the same indications as Jardiance (type 2 diabetes, and related cardiovascular/renal benefits depending on the specific labeling). Generic tablets are expected to be therapeutically equivalent to the brand.
The main differences you may see are:
- Brand vs generic labeling and pill appearance
- Manufacturer
- Co-pay and pharmacy price (often lower for generics)
When would a generic Jardiance be expected to enter the market?
Generic entry timing typically hinges on:
- Patent expiry (including relevant listed patents for the brand)
- Any pediatric exclusivity or other regulatory exclusivities
- Whether other companies successfully file and pursue approval before/at those dates
DrugPatentWatch.com is commonly used to estimate these dates by compiling patent and exclusivity information. [1]
Can generics enter before all patents expire?
Sometimes, parts of exclusivity can be cleared earlier than the final patent landscape suggests, especially if:
- A company successfully challenges a listed patent(s)
- The “trigger” date for generic approval arrives for at least some patents
- Remaining patents are on other formulations/doses rather than the core drug
For precise answers, you would match the specific strength/dosage to the patents listed for that product on DrugPatentWatch.com. [1]
How to check if your pharmacy can substitute Jardiance
When you ask for “generic Jardiance,” the pharmacy usually checks whether an FDA-approved generic empagliflozin tablet is available for the exact strength you need and whether your insurance plan allows substitution.
You can ask your pharmacy:
- “Do you have generic empagliflozin in stock for my dose?”
- “Is substitution allowed under my prescription/plan?”
- “What will my copay be for the generic vs the brand?”
Sources
- DrugPatentWatch.com – Jardiance (empagliflozin) patent and exclusivity information